Impaired Intestinal Wound Healing in Fhl2-deficient Mice is Due to Disturbed Collagen Metabolism
Overview
Authors
Affiliations
Four and one half LIM domain protein FHL2 participates in many cellular processes involved in tissue repair such as regulation of gene expression, cytoarchitecture, cell adhesion, migration and signal transduction. The repair process after wounding is initiated by the release of peptides and bioactive lipids. These molecules induce synthesis and deposition of a provisional extracellular matrix. We showed previously that sphingosine-1-phosphate (S1P) triggers a signal transduction cascade mediating nuclear translocation of FHL2 in response to activation of the RhoA GTPase. Our present study shows that FHL2 is an important signal transducer influencing the outcome of intestinal anastomotic healing. Early wound healing is accompanied by reconstitution and remodelling of the extracellular matrix and collagen is primarily responsible for wound strength. Our results show that impaired intestinal wound healing in Fhl2-deficient mice is due to disturbed collagen III metabolism. Impaired collagen III synthesis reduced the mechanical stability of the anastomoses and led to lower bursting pressure in Fhl2-deficient mice after surgery. Our data confirm that FHL2 is an important factor regulating collagen expression in the early phase of wound healing, and thereby is critically involved in the physiologic process of anastomosis healing after bowel surgery and thus may represent a new therapeutic target.
Knockout Genes in Bowel Anastomoses: A Systematic Review of Literature Outcomes.
Geropoulos G, Psarras K, Koimtzis G, Fornasiero M, Anestiadou E, Geropoulos V J Pers Med. 2024; 14(6).
PMID: 38929776 PMC: 11205243. DOI: 10.3390/jpm14060553.
Volf J, Rajova J, Babak V, Seidlerova Z, Rychlik I Animals (Basel). 2021; 11(11).
PMID: 34827887 PMC: 8614574. DOI: 10.3390/ani11113155.
Four-And-A-Half LIM-Domain Protein 2 (FHL2) Deficiency Aggravates Cholestatic Liver Injury.
Sommer J, Dorn C, Gabele E, Bataille F, Freese K, Seitz T Cells. 2020; 9(1).
PMID: 31963815 PMC: 7016690. DOI: 10.3390/cells9010248.
Pirfenidone attenuates lung fibrotic fibroblast responses to transforming growth factor-β1.
Jin J, Togo S, Kadoya K, Tulafu M, Namba Y, Iwai M Respir Res. 2019; 20(1):119.
PMID: 31185973 PMC: 6558902. DOI: 10.1186/s12931-019-1093-z.
Steiger H, Booij L, Kahan E, McGregor K, Thaler L, Fletcher E J Psychiatry Neurosci. 2019; 44(3):205-213.
PMID: 30693739 PMC: 6488489. DOI: 10.1503/jpn.170242.